Quantcast
Last updated on April 25, 2014 at 5:51 EDT

Latest Echo Stories

2013-01-07 08:28:59

PHILADELPHIA, Jan. 7, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony(®) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today issued the following corporate update to its shareholders: To Our Shareholders: As we begin the new year, we are pleased to report that the last year was one of significant accomplishment and progress that has set the stage for a very exciting...

2012-12-27 16:22:34

PHILADELPHIA, Dec. 27, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony(®) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced the closing of a previously announced underwritten public offering of 3,200,000 shares of its common stock and the fully exercised over-allotment option to purchase 480,000 additional shares, offered at a price of $0.95 per share. The gross...

2012-12-20 20:22:23

PHILADELPHIA, Dec. 20, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony(®) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share. The gross proceeds to Echo from this offering are expected to be approximately $3.0...

2012-11-29 08:28:59

PHILADELPHIA, Nov. 29, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony(®) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced that Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics will present at the Canaccord Genuity 2012 Medical Technology & Diagnostics Forum. (Logo: http://photos.prnewswire.com/prnh/20120801/NE50071LOGO) Dr. Mooney will make a corporate...

2012-11-09 12:28:21

NEW YORK, Nov. 9, 2012 /PRNewswire/ -- With the holidays almost upon us, Echo is kicking off the season early by giving AND gifting across several major Pinterest categories. As part of an extended partnership with noted fashion blog Honestly...WTF and Real Simple, Echo will launch three separate Pinterest sweepstakes that will each feature a separate Echo pin board highlighting products that capture a part of Echo's mantra, Print.Pattern.Color. Entrants will then have the opportunity to...

2012-09-04 02:29:00

PHILADELPHIA, Sept. 4, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics, will present at the Rodman & Renshaw Annual Global Investment Conference. (Logo:...

2012-08-23 02:24:09

CHARLOTTE, N.C., Aug. 23, 2012 /PRNewswire/ -- Affirming the power of free speech and expression, The Echo Foundation celebrates powerful photojournalism with a two-part series that addresses justice, democracy and humanity. While honoring the work of a respected force in photojournalism, the foundation engages the next generation of emerging photographers. Echo's election year series - "We the People. The Voices and Vision of Democracy." - proudly presents the extraordinary work of revered...

2012-08-09 02:29:35

PHILADELPHIA, Aug. 9, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced that Platinum-Montaur Life Sciences, LLC (Montaur) will provide Echo a credit facility of up to $20 million. The company believes that this transaction will provide Echo with the capital...

2012-08-02 06:23:44

NEW YORK, Aug. 2, 2012 /PRNewswire/ -- The Echo System, the return on social company, today announced the availability of its innovative Echo Effect Analytics, an interactive platform that allows businesses to measure their return on social investments, identify influencers, and collect shopping, sharing, interest, and influence data on 100% of their website visitors. Current social analytics platforms often leave marketers' questions unanswered, fail to pinpoint measurable ROI numbers and...

2012-07-25 06:27:11

NEW YORK, July 25, 2012 /PRNewswire/ -- The Echo System, the return on social company, today announced the release of its second Echo Rank index, a proprietary list that gauges how ecommerce firms are leveraging social to drive sales. For the June ranking, The Echo System incorporated the latest list of top ecommerce brands and altered its ranking algorithm to place increased emphasis on how brands are integrating social into their commercial efforts. The top five companies on the June Echo...